AVENUE THERAPEUTICS, INC.

For the period ended Dec 31, 2025. Filed Mar 30, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 30, 2026

ATXI$0.42-50.7%Stored close · as of Mar 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands, except share and per share amounts)

	December 31,	December 31,
	2025	2024
ASSETS
Current assets:
Cash and cash equivalents	$2,855	$2,594
Prepaid expenses and other current assets	76	78
Total assets	$2,931	$2,672
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$468	$654
Accounts payable and accrued expenses - related party	630	146
Warrant liability	1	16
Total current liabilities	1,099	816
Total liabilities	1,099	816
Commitments and Contingencies (Note 6)
Stockholders’ equity
Preferred stock ($0.0001 par value), 2,000,000 shares authorized
Class A Preferred stock, 250,000 shares issued and outstanding as of December 31, 2025 and 2024, respectively	—	—
Common stock ($0.0001 par value)
Common shares, 200,000,000 shares authorized, 3,183,558 and 2,108,670 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively	—	—
Additional paid-in capital	107,321	105,377
Accumulated deficit	(105,489)	(102,580)
Total stockholders’ equity attributed to the Company	1,832	2,797
Non-controlling interests	—	(941)
Total stockholders’ equity	1,832	1,856
Total liabilities and stockholders’ equity	$2,931	$2,672

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.